Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. (2021)

First Author: Fu DJ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamaophthalmol.2020.5044

PubMed Identifier: 33211064

Publication URI: http://europepmc.org/abstract/MED/33211064

Type: Journal Article/Review

Volume: 139

Parent Publication: JAMA ophthalmology

Issue: 1

ISSN: 2168-6165